Testing effectiveness (Phase 2)Study completedNCT01000649What this trial is testingEffects of the V1a Agonist FE 202158 in Patients With Septic ShockWho this might be right forSeptic Shock Ferring Pharmaceuticals 53
Testing effectiveness (Phase 2)Ended earlyNCT03378466What this trial is testingHeparin Anticoagulation in Septic ShockWho this might be right forSeptic ShockVasodilatory Shock University of Manitoba 178
Not applicableStudy completedNCT03266302What this trial is testingHemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients With Infective EndocarditisWho this might be right forInfective Endocarditis Jena University Hospital 288
Post-approval studies (Phase 4)Enrolling By InvitationNCT07212686What this trial is testingSynthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory HypotensionWho this might be right forVasodilatory Shock Todd Sweberg 30
Testing effectiveness (Phase 2)Study completedNCT01612676What this trial is testingInvestigating FE 202158 as Potential Primary Treatment in Patients With Early Septic ShockWho this might be right forSeptic Shock Ferring Pharmaceuticals 31
Not applicableUnknownNCT01532505What this trial is testingEffect of Vasopressin on Tissue Oxygen Saturation in Cardiac Surgery Patients During Cardiopulmonary BypassWho this might be right forHypotensionPoor Peripheral Perfusion Mohamed Ismail 40
Not applicableStudy completedNCT06953297What this trial is testingVasopressin Use in Septic Shock From TürkiyeWho this might be right forSeptic ShockVasodilatory ShockCritical Illness Sepsis, Severe+3 more Karadeniz Technical University 146
Post-approval studies (Phase 4)Study completedNCT05824767What this trial is testingSerum Biomarkers to Predict Response to Angiotensin II in Septic ShockWho this might be right forSeptic ShockVasodilatory Shock University of New Mexico 40
Very early researchActive Not RecruitingNCT07568275What this trial is testingComparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial ElastanceWho this might be right forSeptic ShockCirrhosisVasodilatory Shock+1 more The Cleveland Clinic 30
Not applicableApproved For MarketingNCT03245528What this trial is testingExpanded Access for LJPC-501Who this might be right forCatecholamine Resistant Hypotension (CRH)Distributive ShockHigh Output Shock+2 more La Jolla Pharmaceutical Company
Testing effectiveness (Phase 2)UnknownNCT03623529What this trial is testingLJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory ShockWho this might be right forCatecholamine-resistant Hypotension (CRH)Distributive ShockHigh Output Shock+1 more La Jolla Pharmaceutical Company 100
Testing effectiveness (Phase 2)Ended earlyNCT02317549What this trial is testingTreatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148Who this might be right forSeptic Shock Leading BioSciences, Inc 8
Large-scale testing (Phase 3)Looking for participantsNCT06351150What this trial is testingEfficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed ShockWho this might be right forVasodilatory Shock Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 214
Not applicableStudy completedNCT04964492What this trial is testingAssessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory ShockWho this might be right forVasoplegiaHemodynamicsIntensive Care Unit+1 more Centre Hospitalier Universitaire, Amiens 18